Clinical Features and Management of Snakebite Envenoming in French Guiana.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
19 10 2020
Historique:
received: 23 09 2020
revised: 11 10 2020
accepted: 14 10 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 17 6 2021
Statut: epublish

Résumé

The management of snakebite (SB) envenoming in French Guiana (FG) is based on symptomatic measures and antivenom (AV) administration (Antivipmyn Tri

Identifiants

pubmed: 33086750
pii: toxins12100662
doi: 10.3390/toxins12100662
pmc: PMC7589911
pii:
doi:

Substances chimiques

Antivenins 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Références

Toxicon. 2020 Jan 15;173:1-4
pubmed: 31726079
Toxicon. 2009 Dec 1;54(7):976-87
pubmed: 19303034
Rev Panam Salud Publica. 2019 Nov 19;43:e92
pubmed: 31772565
PLoS One. 2018 Aug 17;13(8):e0202361
pubmed: 30118505
BMJ. 2004 Nov 13;329(7475):1129
pubmed: 15539665
PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006068
pubmed: 29176824
Clin Toxicol (Phila). 2020 Apr;58(4):266-274
pubmed: 31264481
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Toxicon. 1994 Sep;32(9):1045-50
pubmed: 7801340
Clin Toxicol (Phila). 2020 Jul 1;:1-7
pubmed: 32609546
Toxicon. 2012 Jul;60(1):70-82
pubmed: 22483847
Am J Trop Med Hyg. 2018 May;98(5):1547-1551
pubmed: 29611503
Toxicon. 2010 Nov;56(6):980-9
pubmed: 20621114
Toxicon. 2018 May;146:138-150
pubmed: 29510161
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Toxicon. 2018 May;146:91-94
pubmed: 29621524
Anaesth Crit Care Pain Med. 2019 Apr;38(2):193-194
pubmed: 30030082
Clin Toxicol (Phila). 2020 May;58(5):388-396
pubmed: 31387401
Intensive Care Med. 2018 Jan;44(1):115-117
pubmed: 28879463
Toxicon. 2005 Jun 15;45(8):951-67
pubmed: 15922768
Rev Soc Bras Med Trop. 2019 Jan 14;52:e20180140
pubmed: 30652788
Toxins (Basel). 2017 Aug 02;9(8):
pubmed: 28767072
Arch Biochem Biophys. 2010 Apr 1;496(1):9-20
pubmed: 20102699
Rev Soc Bras Med Trop. 2019 Dec 20;53:e20190305
pubmed: 31859953
Clin Toxicol (Phila). 2010 Jan;48(1):57-60
pubmed: 20095815
Zookeys. 2018 Jun 5;(764):27-90
pubmed: 29899674
Rev Soc Bras Med Trop. 2018 May-Jun;51(3):338-346
pubmed: 29972565
Int J Environ Res Public Health. 2018 Sep 27;15(10):
pubmed: 30261677
Trans R Soc Trop Med Hyg. 2004 Jan;98(1):28-42
pubmed: 14702836
Toxins (Basel). 2019 Jan 07;11(1):
pubmed: 30621001
Biochimie. 2015 Nov;118:60-70
pubmed: 26276061
J Allergy Clin Immunol. 2006 Feb;117(2):391-7
pubmed: 16461139
Lancet Glob Health. 2019 Jul;7(7):e837-e838
pubmed: 31129124
Am J Trop Med Hyg. 2020 Jan;102(1):232-240
pubmed: 31628740
PLoS Negl Trop Dis. 2018 Jul 19;12(7):e0006482
pubmed: 30024888
Case Rep Med. 2019 Mar 4;2019:6324569
pubmed: 30949208
Toxicon. 2018 May;146:87-90
pubmed: 29621529

Auteurs

Dabor Resiere (D)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.
Intensive Care Unit, Martinique University Hospital, 97261 Martinique, France.

Stéphanie Houcke (S)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Jean Marc Pujo (JM)

Emergency Department, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Claire Mayence (C)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Cyrille Mathien (C)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Flaubert NkontCho (F)

Pharmacy Department, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Nicaise Blaise (N)

Pharmacy Department, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Magalie Pierre Demar (MP)

Laboratory department, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Didier Hommel (D)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Hatem Kallel (H)

Intensive Care Unit, Cayenne General Hospital, 97300 Cayenne, French Guiana, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH